Inst Diagnosti (INDISA.SN) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Facilities · Chile · ISIN CL0000001587

Price
2,340.40 CLP
Market cap
363.46 bn CLP
P/E (2025)
23.21
P/S (2025)
1.33
Dividend yield
1.78 %
Net margin
5.75 %
Return on equity (ROE)
7.56 %
Return on assets (ROA)
3.83 %

Inst Diagnosti financials

Fiscal year20242025
Revenue239.07 bn CLP272.31 bn CLP
Gross profit58.11 bn CLP70.68 bn CLP
Operating income14.65 bn CLP12.57 bn CLP
EBIT15.61 bn CLP22.91 bn CLP
Net income7.28 bn CLP15.66 bn CLP
Diluted EPS – continuing operations49.59 CLP100.84 CLP

Full history since 2014, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Inst Diagnosti

Instituto de Diagnóstico S.A. provides health services in Chile. It offers patient information and exams instruction, and online services; specialties services; and outpatient services including urgency, laboratory, imaging, vaccination, blood bank, outpatient procedures, and reproductive medicine unit. The company also provides hospitalization services, such as maternity, adult and pediatric hospitalization, adult critical patient unit, pavilion and surgical procedures, neonatology, and robotic surgery; and telemedicine services comprising online consultation and rehabilitation. In addition, it operates health centers, which includes metabolic surgery and nutrition, thyroid and parathyroid, physical medicine and rehabilitation, endometriosis, hemodynamics service, and dialysis centers, as well as provide insurance products. Further, the company offers research and training services, as well as newborn, school, and accident agreements. Instituto de Diagnóstico S.A. was founded in 1961 and is headquartered in Providencia, Chile.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.